Page last updated: 2024-08-22

galactosamine and madecassoside

galactosamine has been researched along with madecassoside in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gao, L; Jiang, W; Li, Q; Liang, F; Lin, C; Wang, W; Wu, L; Xu, L; Zhang, Q; Zhang, Z; Zhao, K; Zhou, M	1

Other Studies

1 other study(ies) available for galactosamine and madecassoside

Article	Year
Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103 Topics: Animals; Antioxidants; Centella; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Heme Oxygenase-1; Lipopolysaccharides; Male; Membrane Proteins; Mice, Inbred Strains; NF-E2-Related Factor 2; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Triterpenes	2018

Article

Year

Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 103

Topics: Animals; Antioxidants; Centella; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Heme Oxygenase-1; Lipopolysaccharides; Male; Membrane Proteins; Mice, Inbred Strains; NF-E2-Related Factor 2; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Triterpenes

2018